FYR Enters Know-How Agreement with Mayo Clinic to Collaborate on Blood-Based Biomarker Solutions for Parkinson’s DiseaseCollaboration aims to use FYR’s AI-enabled EV-Omics (EVO) platform to produce dynamic, real-time insights into Parkinson’s disease
FYR Appoints Chris Howlett to its Board of DirectorsAppointment adds business, market and partner development expertise to FYR board
